prothionamide and AIDS-Related-Opportunistic-Infections

prothionamide has been researched along with AIDS-Related-Opportunistic-Infections* in 1 studies

Other Studies

1 other study(ies) available for prothionamide and AIDS-Related-Opportunistic-Infections

ArticleYear
[Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
    Pneumologie (Stuttgart, Germany), 1995, Volume: 49, Issue:2

    Multiresistant tuberculoses are on the increase. The conversion rates in "additional" therapy are only modest. 17 multiresistant patients and 6 treatment-refractory tuberculoses were treated by us with ofloxacin-cycloserin-protionamide-INH. 16 of these patients were HIV positive. 21 patients converted after 3 months of treatment by the latest. 3 patients died of HIV syndrome. There was otherwise no difference between HIV positive and HIV negative patients. As a rule, the combination was well tolerated. In multiresistant tuberculosis, it is mandatory to administer at least 3 drugs to which there is no resistance.

    Topics: Adult; AIDS-Related Opportunistic Infections; Cycloserine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Prothionamide; Recurrence; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

1995